Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
8,129,935
-
Shares change
-
+522,373
-
Total reported value, excl. options
-
$118,780,218
-
Value change
-
+$7,349,747
-
Put/Call ratio
-
1.36%
-
Number of buys
-
33
-
Number of sells
-
-39
-
Price
-
$14.61
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2023
94 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2023.
AVITA Medical, Inc. - Common Stock (RCEL) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,129,935 shares
of 26,475,256 outstanding shares and own 30.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,717,282 shares), VANGUARD GROUP INC (1,360,696 shares), GEODE CAPITAL MANAGEMENT, LLC (498,618 shares), Driehaus Capital Management LLC (495,768 shares), PURA VIDA INVESTMENTS, LLC (480,643 shares), STATE STREET CORP (469,141 shares), Russell Investments Group, Ltd. (368,465 shares), EAM Investors, LLC (249,192 shares), NORTHERN TRUST CORP (218,604 shares), and Calamos Advisors LLC (210,796 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.